MedTrace Logo

PRODIGY Registry in NYHA Class III Heart Failure Patients

NCT03623165 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2019-08-19

No results posted yet for this study

Summary

This is an observational, prospective, single arm, multi-center registry to evaluate the Cordella™ Heart Failure System (CHFS) in up to 250 NYHA Class III HF patients .

Conditions

  • Heart Failure NYHA Class III

Interventions

DEVICE

Cordella™ Heart Failure System

The Cordella™ Heart Failure System electronically transfers communications and data from a set of medical devices in a heart failure patient's home to a database for storage, retrieval, and display to healthcare providers.

Sponsors & Collaborators

  • Endotronix, Inc.

    lead INDUSTRY

Principal Investigators

  • Andrea Sauerland · Endotronix, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2019-08-15
Completion
2019-08-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03623165 on ClinicalTrials.gov